Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Tremblay

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Blood Reviews|August 31, 2024
Ven the dose matters: Venetoclax dosing in the frontline treatment of AMLDahniel Sastow, Hannah Levavi, Nicole Wagner, et al.
Blood Reviews|April 24, 2016
Ironing out the details of iron overload in myelofibrosis: Lessons from myelodysplastic syndromesNicole Carreau, Douglas Tremblay, Michael Savona, et al.
Leukemia & Lymphoma|November 12, 2022
Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabineJonathan Feld, Douglas Tremblay, Shyamala C Navada, et al.
International Journal of Laboratory Hematology|August 14, 2020
Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosisJonathan Feld, Douglas Tremblay, Santiago Thibaud, et al.
Clinical Transplantation|November 22, 2020
The utility of thrombophilia and hematologic screening in live liver donationLeonard Naymagon, Douglas Tremblay, Marcelo Facciuto, et al.
Oncology (Williston Park, N.Y.)|May 31, 2018
Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid MalignanciesKelsey Sokol, Douglas Tremblay, Sheena Bhalla, et al.
Oncology (Williston Park, N.Y.)|April 24, 2018
Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid LeukemiaDouglas Tremblay, Kelsey Sokol, Sheena Bhalla, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 13, 2024
Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database AnalysisSerena Tharakan, Jonathan Feld, Grace Van Hyfte, et al.
Molecular Plant Pathology|June 24, 2010
The Potato virus Y M(S)N(R) NIb-replicase is the elicitor of a veinal necrosis-hypersensitive response in root knot nematode resistant tobaccoJohn P Fellers, Douglas Tremblay, Margaret F Handest, et al.
Cureus|October 23, 2023
Dasatinib-Associated Acneiform Eruption Successfully Treated With Sarecycline in a Patient With Chronic Myeloid LeukemiaDina Poplausky, Jade N Young, Danielle P Dubin, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Blood Reviews|August 31, 2024
Ven the dose matters: Venetoclax dosing in the frontline treatment of AMLDahniel Sastow, Hannah Levavi, Nicole Wagner, et al.
Blood Reviews|April 24, 2016
Ironing out the details of iron overload in myelofibrosis: Lessons from myelodysplastic syndromesNicole Carreau, Douglas Tremblay, Michael Savona, et al.
Leukemia & Lymphoma|November 12, 2022
Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabineJonathan Feld, Douglas Tremblay, Shyamala C Navada, et al.
International Journal of Laboratory Hematology|August 14, 2020
Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosisJonathan Feld, Douglas Tremblay, Santiago Thibaud, et al.
Clinical Transplantation|November 22, 2020
The utility of thrombophilia and hematologic screening in live liver donationLeonard Naymagon, Douglas Tremblay, Marcelo Facciuto, et al.
Oncology (Williston Park, N.Y.)|May 31, 2018
Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid MalignanciesKelsey Sokol, Douglas Tremblay, Sheena Bhalla, et al.
Oncology (Williston Park, N.Y.)|April 24, 2018
Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid LeukemiaDouglas Tremblay, Kelsey Sokol, Sheena Bhalla, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 13, 2024
Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database AnalysisSerena Tharakan, Jonathan Feld, Grace Van Hyfte, et al.
Molecular Plant Pathology|June 24, 2010
The Potato virus Y M(S)N(R) NIb-replicase is the elicitor of a veinal necrosis-hypersensitive response in root knot nematode resistant tobaccoJohn P Fellers, Douglas Tremblay, Margaret F Handest, et al.
Cureus|October 23, 2023
Dasatinib-Associated Acneiform Eruption Successfully Treated With Sarecycline in a Patient With Chronic Myeloid LeukemiaDina Poplausky, Jade N Young, Danielle P Dubin, et al.
Pageof 11